CTLA-4lg in combination with anti-CD40L prolongs xenograft survival and inhibits anti-Gal Ab production in GT-Ko mice

12Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The generation of GT-Ko mice has provided unique opportunities to study allograft and xenograft rejection in the context of anti-α1,3-Gal antibody (anti-Gal Ab) responses. In this study we used the allotrans-plantation model of C3H hearts into galactosyl-transferase-deficient (GT-Ko) mice and the xenotrans-plantation model of baby Lewis rat hearts into GT-Ko mice to investigate the ability of CTLA-4lg in combination with anti-CD40L mAb to control graft rejection and anti-Gal Ab production. Murine CTLA-4lg or anti-CD40L monotherapy prolonged allograft survival, and the combination of these reagents was most immuno-suppressive. However short-term treatment with murine cytotoxic T lymphocyte associated antigen-4 (muCTLA-4lg) and/or CD40 ligand (CD154) monoclonal antibodies (anti-CD40L mAbs) was unable to induce indefinite allograft survival. CTLA-4-immunoglobulin fusion protein (CTLA-4lg) or anti-CD40L monotherapy only marginally prolonged xenograft survival; the combination of human CTLA-4lg and anti-CD40L significantly prolonged xenograft survival (74days), while the combination of murine CTLA-4lg and anti-CD40L resulted in graft survival of >120days. CTLA-4lg or anti-CD40L monotherapy or the combination of these agents inhibited the production of alloAbs, including anti-Gal Abs. CTLA-4lg or anti-CD40L monotherapy partially controlled xenoAb and anti-Gal Ab production, while the combination was more effective. These observations corroborate our previous observations that humoral, including anti-Gal Ab, responses and rejection following allograft or concordant xenograft transplantation in GT-Ko mice are T-cell dependent and can be controlled by co-stimulation blockade.

Cite

CITATION STYLE

APA

Yin, D., Ma, L., Shen, J., Byrne, G. W., Logan, J. S., & Chong, A. S. F. (2002). CTLA-4lg in combination with anti-CD40L prolongs xenograft survival and inhibits anti-Gal Ab production in GT-Ko mice. American Journal of Transplantation, 2(1), 41–47. https://doi.org/10.1034/j.1600-6143.2002.020108.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free